Trump's pharmaceutical tariffs could affect some drugmakers more than others
UNITED STATES, JUL 29 – Tariffs on imported drugs may reduce free cash flow for some drugmakers and could prompt shifts in manufacturing and research spending, analysts say.
8 Articles
8 Articles
How will Trump’s E.U. tariffs affect drug prices?
President Donald Trump’s trade deal with the European Union may lead to higher prices for brand-name drugs in the United States, including blockbuster medications like Ozempic and Wegovy, experts say. The trade deal, announced Sunday, places a 15% tariff on most imported goods from the E.U., including pharmaceuticals. While that comes in well below the 200% tariffs Trump had threatened on pharmaceutical imports earlier this month, it’ll still ha…
Today's South Florida News
President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and they may have a bigger impact on some drugmakers than others. AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned” based on their manufacturing footprint in the U.S. compared to abroad, while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said in a note. Still, it is unclear what those levie…
Trump’s pharmaceutical tariffs could affect some drugmakers more than others – DG Verifications & Stats
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some analysts. Trump told reporters earlier this month that his administration will begin implementing low pharmaceutical levies as early…
Trump's pharmaceutical tariffs could affect some drugmakers more than others - Daily news Update
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some analysts. Trump told reporters earlier this month that his administration will begin implementing low pharmaceutical levies as earl…
Coverage Details
Bias Distribution
- 83% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium